Guest: R. Scott Wright, M.D.
Host: Stephen L. Kopecky, M.D.
RNA therapies are rising in quantity as focused therapies for dyslipidemia together with LDL-c, Lp(a) and Triglycerides. The podcast will discover the science behind these therapies, the proof for security and the way clinicians can make the most of them of their practices.
Topics Discussed:
• What are the brand new RNA therapies accessible or quickly to be accessible?
• How are RNA based mostly therapies getting used?
• How do they evaluate to the COVID-19 vaccine?
• What is their effectiveness and facet impact profile?
• Are there unwanted side effects or issues?
From Mayo Clinic to your inbox, sign-up free of charge: https://mayocl.in/3e71zfi
Visit Mayo Clinic: https://mayocl.in/2COVmlm
Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/
Follow Mayo Clinic on Instagram: https://www.instagram.com/mayoclinic/
Follow Mayo Clinic on X, previously Twitter: https://x.com/MayoClinic
Follow Mayo Clinic on Threads: https://www.threads.net/@mayoclinic
